ACUTE LYMPHOBLASTIC LEUKEMIAS WITH DELETION OF 11Q23 OR A NOVEL INVERSION (11)(P13Q23) LACK MLL-GENE REARRANGEMENTS AND HAVE FAVORABLE CLINICAL-FEATURES
Sc. Raimondi et al., ACUTE LYMPHOBLASTIC LEUKEMIAS WITH DELETION OF 11Q23 OR A NOVEL INVERSION (11)(P13Q23) LACK MLL-GENE REARRANGEMENTS AND HAVE FAVORABLE CLINICAL-FEATURES, Blood, 86(5), 1995, pp. 1881-1886
Balanced translocations affecting the 11q23 region are among the most
frequent chromosomal abnormalities in childhood acute lymphoblastic le
ukemia (ALL), comprising 5% to 6%. These cases consistently have a rea
rranged MLL gene and are associated with high-risk presenting features
, hyperleukocytosis and younger age, and a poor treatment outcome. To
assess the clinical and biologic significance of 11q23-associated stru
ctural chromosomal abnormalities other than translocations, we studied
17 cases of childhood ALL [14 with del(11)(q23) and 3 with inv(11)(p1
2q23)] that were identified among 785 cases with successful chromosome
analysis. In contrast to reported cases with 11q23 and MLL gene rearr
angement, our series was characterized by relatively low leukocyte cou
nts (median, 15.1 x 10(9)/L), expression of CD10 antigen but not myelo
id-associated CD15 and CDw65 antigens, a relatively high frequency of
T-cell immunophenotypes, and a generally favorable prognosis. All 13 c
ases with interpretable molecular analysis lacked MLL gene rearrangeme
nts. We suggest that most cases with deletions or inversions affecting
the 11q23 region represent clinically and biologically different enti
ties as compared with those defined by 11q23 translocation. (C) 1995 b
y The American Society of Hematology.